{"id":"W4390024431","doi":"10.1016/j.clgc.2023.12.010","title":"Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Eisai Incorporated; Eisai Canada","keywords":"Medicine; Lenvatinib; Adverse effect; Pembrolizumab; Sunitinib; Internal medicine; Rash; Renal cell carcinoma; Oncology; Intensive care medicine; Cancer; Thyroid cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006544271,0.0001223014,0.0003434154,0.00025582,0.0003752371,0.0004251177,0.00014747,0.000211987,0.0006775471],"category_scores_gemma":[0.002863814,0.00007408592,0.000370657,0.0002679951,0.00006851532,0.0001930005,0.0001519635,0.0005294677,0.00009984383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004939844,"about_ca_system_score_gemma":0.0004083256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008902064,"about_ca_topic_score_gemma":0.002305109,"domain_scores_codex":[0.9995295,0.0002278354,0.00007289193,0.00002659938,0.000101018,0.00004208912],"domain_scores_gemma":[0.9993361,0.0002147926,0.0002632824,0.00001567851,0.00008060971,0.00008955443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005250208,0.0008361134,0.6396668,0.0007279703,0.000831185,0.005153443,0.0005520409,0.001092519,0.007507187,0.0001607539,0.0041997,0.3340222],"study_design_scores_gemma":[0.0006792945,0.006430962,0.9499586,0.0003860981,0.0009935007,0.01901982,0.0008842177,0.003358467,0.003959321,0.0002701517,0.01402717,0.00003244058],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973837,0.01633049,0.0007343307,0.001436753,0.00009920889,0.0001411267,0.0001173277,0.00002882221,0.007274864],"genre_scores_gemma":[0.9964264,0.001955945,0.0005165924,0.0005914373,0.00009429899,0.00002863597,0.00007109398,0.000003522387,0.0003120239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008902064,"threshold_uncertainty_score":0.003584146,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03796370185734156,"score_gpt":0.3437432847666835,"score_spread":0.305779582909342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}